Research Analysts’ Upgrades for January, 4th (ABUS, ACET, ALDR, AVDL, BIOS, BLCM, BOBE, BOJA, CAFD, CLLS)

Research Analysts’ upgrades for Thursday, January 4th:

Arbutus Biopharma (NASDAQ:ABUS) was upgraded by analysts at BidaskClub from a sell rating to a hold rating.

Aceto (NASDAQ:ACET) was upgraded by analysts at BidaskClub from a strong sell rating to a sell rating.

Alder BioPharmaceuticals (NASDAQ:ALDR) was upgraded by analysts at BidaskClub from a sell rating to a hold rating.

Avadel Pharmaceuticals plc – American Depositary Shares each representing one Ordinary Share (NASDAQ:AVDL) was upgraded by analysts at BidaskClub from a strong sell rating to a sell rating.

BioScrip (NASDAQ:BIOS) was upgraded by analysts at BidaskClub from a hold rating to a buy rating.

Bellicum Pharmaceuticals (NASDAQ:BLCM) was upgraded by analysts at BidaskClub from a strong sell rating to a sell rating.

Bob Evans Farms (NASDAQ:BOBE) was upgraded by analysts at BidaskClub from a strong sell rating to a sell rating.

Bojangles (NASDAQ:BOJA) was upgraded by analysts at BidaskClub from a strong sell rating to a sell rating.

8Point3 Energy Partners (NASDAQ:CAFD) was upgraded by analysts at BidaskClub from a hold rating to a buy rating.

Cellectis (NASDAQ:CLLS) was upgraded by analysts at BidaskClub from a buy rating to a strong-buy rating.

Clorox (NYSE:CLX) was upgraded by analysts at Bank of America Corp from an underperform rating to a neutral rating.

Cimpress (NASDAQ:CMPR) was upgraded by analysts at BidaskClub from a hold rating to a buy rating.

CNH Industrial (NYSE:CNHI) was upgraded by analysts at Deutsche Bank AG from a hold rating to a buy rating. The firm currently has $16.00 target price on the stock.

California Resources (NYSE:CRC) was upgraded by analysts at Bank of America Corp from an underperform rating to a neutral rating.

Crispr Therapeutics (NASDAQ:CRSP) was upgraded by analysts at BidaskClub from a hold rating to a buy rating.

Cardiovascular Systems (NASDAQ:CSII) was upgraded by analysts at BidaskClub from a strong sell rating to a sell rating.

CommVault Systems (NASDAQ:CVLT) was upgraded by analysts at BidaskClub from a strong sell rating to a sell rating.

CVS Health (NYSE:CVS) was upgraded by analysts at UBS Group AG from an outperform rating to a strong-buy rating.

Concho Resources (NYSE:CXO) was upgraded by analysts at Bank of America Corp from a neutral rating to a buy rating.

Domino's Pizza (NYSE:DPZ) was upgraded by analysts at Credit Suisse Group AG from a neutral rating to an outperform rating. Credit Suisse Group AG currently has $220.00 price target on the stock. They noted that the move was a valuation call. The analysts noted that the move was a valuation call.

DryShips (NASDAQ:DRYS) was upgraded by analysts at BidaskClub from a sell rating to a hold rating.

Davita (NYSE:DVA) was upgraded by analysts at Bank of America Corp from a neutral rating to a buy rating.

DexCom (NASDAQ:DXCM) was upgraded by analysts at BidaskClub from a buy rating to a strong-buy rating.

Encompass Health (NYSE:EHC) was upgraded by analysts at Bank of America Corp from an underperform rating to a neutral rating.

Energizer (NYSE:ENR) was upgraded by analysts at Deutsche Bank AG from a hold rating to a buy rating.

Edwards Lifesciences (NYSE:EW) was upgraded by analysts at Barclays PLC from an equal weight rating to an overweight rating.

F5 Networks (NASDAQ:FFIV) was upgraded by analysts at BMO Capital Markets from a market perform rating to an outperform rating.

Twenty-First Century Fox (NASDAQ:FOXA) was upgraded by analysts at Wells Fargo & Co to a market weight rating.

GP Strategies (NYSE:GPX) was upgraded by analysts at B. Riley from a neutral rating to a buy rating. They currently have $28.00 price target on the stock, up from their previous price target of $24.50.

Hologic (NASDAQ:HOLX) was upgraded by analysts at Bank of America Corp from a neutral rating to a buy rating. Bank of America Corp currently has $50.00 target price on the stock.

InterDigital (NASDAQ:IDCC) was upgraded by analysts at BidaskClub from a strong sell rating to a sell rating.

Lincoln Electric (NASDAQ:LECO) was upgraded by analysts at UBS Group AG from a market perform rating to an outperform rating.

Marathon Oil (NYSE:MRO) was upgraded by analysts at Bank of America Corp from a neutral rating to a buy rating.

Neurocrine Biosciences (NASDAQ:NBIX) was upgraded by analysts at BidaskClub from a hold rating to a buy rating.

Newfield Exploration (NYSE:NFX) was upgraded by analysts at Bank of America Corp from a neutral rating to a buy rating.

NuVasive (NASDAQ:NUVA) was upgraded by analysts at Needham & Company LLC from a hold rating to a buy rating. Needham & Company LLC currently has $71.00 price target on the stock. The analysts wrote, “We are upgrading NUVA to Buy from Underperform since: 1) we believe that consensus revenue and EPS estimates have declined to levels that are more realistic and likely conservative, 2) NUVA has done several acquisitions that probably aren’t fully factored into consensus revenue or EPS estimates (Vertera and SafePassage, which we estimate could add ~2% to NUVA’s 2018 revenue), 3) NUVA should see a significant benefit from tax reform (which we expect to increase its EPS by ~15% in 2018), and 4) we think NUVA shares are attractively valued considering the expected benefit from tax reform. We have raised our revenue and EPS estimates to reflect recent deals and tax reform.””

Grupo Aeroportuario del Centro Norte (NASDAQ:OMAB) was upgraded by analysts at BidaskClub from a sell rating to a hold rating.

OneMain (NYSE:OMF) was upgraded by analysts at Compass Point from a neutral rating to a buy rating.

Orbotech (NASDAQ:ORBK) was upgraded by analysts at BidaskClub from a hold rating to a buy rating.

Ocean Rig UDW Inc. New (NASDAQ:ORIG) was upgraded by analysts at BidaskClub from a strong sell rating to a sell rating.

On Track Innovations (NASDAQ:OTIV) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “On Track is a global leader in contactless microprocessor-based smart card systems. “

Oxford Industries (NYSE:OXM) was upgraded by analysts at DA Davidson from a neutral rating to a buy rating. They currently have $91.00 price target on the stock.

Occidental Petroleum (NYSE:OXY) was upgraded by analysts at Zacks Investment Research from a hold rating to a strong-buy rating. The firm currently has $85.00 price target on the stock. According to Zacks, “Occidental Petroleum’s shares have gained higher than the industry in the last six months. As Oil prices continue to improve, Occidental Petroleum will benefit from more oil production in the Permian Resources and from concentrating on high margin production region. The fundamental strength of the company will help it overcome the adverse impact from natural disasters. The company generates stable cash flow and its Chemical plant will further improve its cash flow.  Occidental Petroleum, like other oil and natural gas companies, faces the risks of cost overruns and development interruptions due to delays in drilling and other approvals, property or border disputes and equipment failures.”

Och-Ziff Capital Management Group (NYSE:OZM) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. Zacks Investment Research currently has $2.75 price target on the stock. According to Zacks, “Och-Ziff Capital Management Group LLC is a leading, global institutional alternative asset management firm. It seeks to deliver consistent positive risk-adjusted returns throughout market cycles, with a strong focus on risk management and capital preservation. Portfolio composition is determined by market opportunities rather than any predetermined commitment to investment discipline or geography. Our diversified, multi-strategy approach is based on global investment strategies, including merger arbitrage, convertible arbitrage, equity restructuring, credit and distressed investments, private investments and real estate. “

Platform Specialty Products (NYSE:PAH) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “Platform Specialty Products Corporation is a producer of high technology specialty chemical products as well as technical services. The company serves electronics, metal and plastic plating, graphic arts, and offshore oil production and drilling industries. Platform Specialty Products Corporation is headquartered in Miami, United States. “

People's United Financial (NASDAQ:PBCT) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. The firm currently has $21.00 price target on the stock. According to Zacks, “Shares of People’s United have outperformed the industry in the past three months. Also, the company has a decent earnings surprise history. It surpassed the Zacks Consensus Estimate for earnings in two of the trailing four quarters. People’s United is steadily growing through acquisitions, which is likely to continue in the near future, given its strong balance sheet position. Also, People’s United’s improving credit quality and easing margin pressure are tailwinds. However, escalating expenses despite undertaking initiatives to curb costs remain a concern.”

Prestige Brands (NYSE:PBH) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “Prestige Brands Holdings, Inc. markets and distributes brand name over-the-counter and household cleaning products, in certain international markets. The Company’s brands include Monistat and Summer’s Eve women’s health products, BC and Goody’s pain relievers, Clear Eyes eye care products, DenTek specialty oral care products, Dramamine motion sickness treatments, Chloraseptic sore throat treatments, Compound W wart treatments, Little Remedies pediatric over-the-counter products, The Doctor’s NightGuard dental protector, Efferdent denture care products, Luden’s throat drops, Beano gas prevention, Debrox earwax remover, Gaviscon antacid in Canada, and Hydralyte rehydration products and the Fess line of nasal and sinus care products. Prestige Brands is a different kind of company. They focus on product innovation and quality in the over-the-counter healthcare and household cleaning categories to better improve the lives of customers and their world. “

Potbelly (NASDAQ:PBPB) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “Potbelly Corporation is a neighborhood sandwich concept. The Company manages establishments for consuming food on premises to offers sandwiches, salads, soups, chili, chips, cookies, ice cream, and smoothies. It serves customers throughout the United States. Potbelly Corporation is headquartered in Chicago, Illinois. “

Potlatch (NASDAQ:PCH) was upgraded by analysts at BidaskClub from a strong sell rating to a sell rating.

Precision Drilling (NYSE:PDS) (TSE:PD) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. Zacks Investment Research currently has $3.50 target price on the stock. According to Zacks, “Precision Drilling Corporation is an oilfield services company. The Company provides contract drilling, well servicing and strategic support services to the oil and gas industry in North America and internationally. It provides land drilling, directional drilling, turnkey drilling, camp and catering services, procures and distributes oilfield supplies. It also offers service rigs for well completion and workover services, snubbing services and wastewater treatment services, tubulars, well control equipment, wellsite accommodations. Precision Drilling Corporation is headquartered in Calgary, Canada. “

Peoples Bancorp (NASDAQ:PEBO) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. The firm currently has $37.00 price target on the stock. According to Zacks, “Peoples Bancorp Inc. is a bank holding company. “

Pennsylvania Real Estate Investment Trust (NYSE:PEI) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. They currently have $14.00 price target on the stock. According to Zacks, “PENNSYLVANIA R.E. INVEST. TR. is a real estate investment trust, engaged in acquiring and holding for investment interests in real estate. “

Principal Financial Group (NYSE:PFG) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. The firm currently has $79.00 target price on the stock. According to Zacks, “Shares of Principal Financial have outperformed the industry in the last three months. Focus on fee-based revenue sources has been helping the company to earn steadily and limits exposure to the interest rate environment. Principal Financial targets a return on equity improvement of 30-60 basis points annually. Its inorganic story remains impressive with buyouts strengthening its international footprint. The company’s assets under management have also been steadily increasing.  It also remains focused on effective capital deployment to enhance the shareholder value, targeting $0.9-$1.3 billion in 2018. However, higher leverage inducing increase in interest weigh on margin expansion remains a headwind. The company is expected to report fourth-quarter results in the last week of January. A Zacks Rank of 2, which increases the predictive power of ESP, and an Earnings ESP of +0.98% makes us confident of a likely positive earnings surprise.”

Profire Energy (NASDAQ:PFIE) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “Profire Energy, Inc. manufactures, installs and services oilfield combustion management systems and related burner products. The Company’s products aid oil and natural gas producers in the safe and efficient development and transportation of carbon-based fuels. Its products include Profire 2100 and the Profire 1100, Profire 1100i and fuel-trains or valve-trains, which comprise piping, valves, and controls related to the process of providing fuel to burners, as well as having safety controllers to monitor operations. Profire Energy, Inc. is based in Lindon, Utah. “

PFSweb (NASDAQ:PFSW) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “PFSWeb Inc. is an international provider of transaction management services for both traditional commerce and electronic commerce, or e-commerce, companies. The company provides a broad range of services, including order management, customer care services, billing services, information management and fulfillment and distribution services. The fulfillment and distribution services are conducted at the warehouses and include picking, packing and shipping the clients’ customer orders. “

Pengrowth Energy (NYSE:PGH) (TSE:PGF) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. Zacks Investment Research currently has $1.00 target price on the stock. According to Zacks, “Pengrowth Energy Trust is a Canadian energy trust with crude oil and natural gas properties in the Western Canadian Sedimentary Basin and offshore the East Coast of Canada. “

Progenics Pharmaceuticals (NASDAQ:PGNX) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. They currently have $6.75 price target on the stock. According to Zacks, “Progenics Pharmaceuticals, Inc. is developing innovative medicines for oncology, with a pipeline that includes several product candidates in later-stage clinical development. Progenics’ first-in-class PSMA-targeted technology platform for prostate cancer includes an antibody drug conjugate therapeutic in a two-cohort phase 2 clinical trial and a small molecule imaging agent that has completed patient dosing in a phase 2 trial. Among other assets in its pipeline of targeted radiotherapy and molecular imaging compounds is Azedra(TM), an ultra-orphan radiotherapy candidate also in a phase 2 study under an SPA. Progenics’ first commercial product, Relistor(R) (methylnaltrexone bromide) for opioid-induced constipation, is partnered with and marketed by Salix Pharmaceuticals, Inc. “

PriceSmart (NASDAQ:PSMT) was upgraded by analysts at BidaskClub from a sell rating to a hold rating.

Quidel (NASDAQ:QDEL) was upgraded by analysts at CL King to a buy rating.

Transocean (NYSE:RIG) was upgraded by analysts at Jefferies Group LLC from a hold rating to a buy rating. The firm currently has $13.00 target price on the stock.

Rigel Pharmaceuticals (NASDAQ:RIGL) was upgraded by analysts at BidaskClub from a sell rating to a hold rating.

Republic Services (NYSE:RSG) was upgraded by analysts at Stifel Nicolaus from a hold rating to a buy rating.

Select Medical (NYSE:SEM) was upgraded by analysts at Bank of America Corp from an underperform rating to a neutral rating.

Sapiens International (NASDAQ:SPNS) was upgraded by analysts at BidaskClub from a sell rating to a hold rating.

Stemline Therapeutics (NASDAQ:STML) was upgraded by analysts at BidaskClub from a hold rating to a buy rating.

Teva Pharmaceutical Industries (NYSE:TEVA) was upgraded by analysts at Citigroup Inc from a neutral rating to a buy rating. The firm currently has $24.00 target price on the stock.

Tegna (NYSE:TGNA) was upgraded by analysts at Wells Fargo & Co from a market perform rating to an outperform rating.

Taylor Morrison Home (NYSE:TMHC) was upgraded by analysts at UBS Group AG from a neutral rating to a positive rating.

Tyme Technologies (NASDAQ:TYME) was upgraded by analysts at BidaskClub from a sell rating to a hold rating.

Umpqua (NASDAQ:UMPQ) was upgraded by analysts at Wedbush from a neutral rating to an outperform rating.

Vantiv (NYSE:VNTV) was upgraded by analysts at Royal Bank of Canada from an outperform rating to a top pick rating.

Validus (NYSE:VR) was upgraded by analysts at Keefe, Bruyette & Woods from a market perform rating to an outperform rating.

Workday (NASDAQ:WDAY) was upgraded by analysts at KeyCorp to an overweight rating.

Wix.Com (NASDAQ:WIX) was upgraded by analysts at UBS Group AG from an outperform rating to a strong-buy rating.

World Acceptance (NASDAQ:WRLD) was upgraded by analysts at BidaskClub from a sell rating to a hold rating.

World Wrestling Entertainment (NYSE:WWE) was upgraded by analysts at Wells Fargo & Co from a market perform rating to an outperform rating.

ZIOPHARM Oncology (NASDAQ:ZIOP) was upgraded by analysts at BidaskClub from a strong sell rating to a sell rating.

Zoetis (NYSE:ZTS) was upgraded by analysts at Citigroup Inc from a neutral rating to a buy rating. The firm currently has $85.00 price target on the stock.

Receive News & Ratings for Arbutus Biopharma Corp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arbutus Biopharma Corp and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply